Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144014
Status:
COMPLETED
Last Update Posted:
2016-06-03
First Post:
2005-09-01
Brief Title:
Safety and Efficacy Study in Acute Ischaemic Stroke
Sponsor:
Vernalis RD Ltd
Organization:
Vernalis RD Ltd
Study Overview
Official Title:
A Phase II Multi-centre Two-part Study to Evaluate the Safety and Efficacy of Study Drug in Acute Ischaemic Stroke
Status:
COMPLETED
Status Verified Date:
2016-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VASST
Brief Summary:
A Phase II study to evaluate the safety and efficacy of five dose levels of study drug in acute ischaemic stroke
Detailed Description:
An open label dose escalation study where patients with acute ischaemic stroke will receive a single intravenous dose of study drug There will be five dose levels with groups of 10 patients in each Escalation to higher doses will occur following review of safety data from the previous dose
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None